Correlation of TGFβ1 overexpression with down-regulation of proliferation-inducing molecules in HPV-11 transformed human tissue xenografts

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 4969-4976

  Shier, Medhat K ^a   Neely, Elizabeth B ^a   Ward, Margaret G ^a   Richards, Mary E ^a   Manders, Ernest C ^a   Meyers, Craig ^a   Howett, Mary K ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

HPV; TGF 1 differentiation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PROTEIN BCL 2; PROTEIN C JUN; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WART VIRUS; XENOGRAFT;

BASE SEQUENCE; CELL DIVISION; CELL TRANSFORMATION, VIRAL; DNA PRIMERS; DOWN-REGULATION; HUMANS; NF-KAPPA B; PAPILLOMAVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0033368230     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Xi LF and Koutsky LA: Epidemiology of genital human papillomavirus infections. Bull Inst Pasteur 95: 161-78, 1997.
2. Schlegel R: Papillomaviruses and human cancers. Sem Virol 1: 297-306, 1990.
3. Laimins LA: The biology of human papillomaviruses: from warts to cancer. Infectious Agents and Disease. 2: 74-86, 1993.
4. DeVilliers, E.M: Human pathogenic papillomavirus types: an update. In: H. Zur Hausen (ed.), Human Pathogenic Papillomaviruses, pp. 1-12. Berlin: Springer, 1994.
5. Zur Hausen H: Papillomavirus infections - a major cause of human cancers. Biochem Biophys Acta 1288: F55-78, 1996A.
6. Kreider JW, Howett MK, Wolfe SA, Bartlett GL, Zaino RJ, Sedlacek T and Mortel R: Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature 317: 639-41, 1985.
7. Kreider JW, Howett MK, Lill NL, Bartlett GL, Zaino RJ, Sedlacek TV and Mortel R: In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata. J Virol 59: 369-76, 1986.
8. Ozbun MA and Meyers C: Transforming growth factor betal induces differentiation in human papillomavirus-positive keratinocytes. J Virol 70: 5437-46, 1996.
9. Kreider JW, Howett MK, Leure Dupree AE, Zaino RJ and Weber JA: Laboratory production in vivo of infectious human papillomavirus type 11. J Virol 61: 590-3, 1987.
10. Hartsough MT and Mulder KM: Transforming growth factor-beta signaling in epithelial cells. Pharmacol Ther 75: 21-41, 1997.
11. Tsakada T, Eguchi K, Migita K, Kawabe Y, Kawakami A, Matsuoka N, Takashima H, Mizokami A, and Nagataki S: Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem Biophys Res Commun 210: 1076-82, 1995.
12. Pietenpol JA, Holt JT, Stein RW, and Moses HL: Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci 87: 3758-62, 1990A.
13. Bos J: Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-9, 1989.
14. Lohman F, Gibbs S, Fischer D, Borgstein AM, Vande Putte P and Backendorf C: Involvement of c-jun in the regulation of terminal differentiation genes in normal and malignant keratinocytes. Oncogene, 14: 1623-7, 1997.
15. Beg AA, Ruben SM, Haskil S, Rosen CA, and Baldwin AS Jr: I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev 6: 1899-913, 1992.
16. Arsura, M, Wu M and Sonenshein GE: TGF betal inhibits NF kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity 5: 31-40, 1996.
17. De Geest K, Bergman CA, Turyk ME, Frank BS and Wilbanks GD: Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor-beta 1. Gynecol Oncol 55: 376-85, 1994.
18. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
19. Rocke EA and Jacobberger JW: Transforming growth factor-β1 (TGFβ1) enhances apoptosis in human papillomavirus type 16-immortalized ectocervical epithelial cells. Exp Cell Res 216: 65-72, 1995.
20. Evan G, Harrington E, Fanidi A, Land H, Amati B and Bennett M: Integrated control of cell proliferation and cell death by c-myc oncogene. Philosophical Transactions of the Royal Society of London- Series B: Biological Sciences 345: 269-75, 1994.
21. Kyo S, Klumpp D, Inoue M, Kanaya T and Laimins LA: Expression of AP-1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J Gen Virol 78: 401-11, 1997.
22. Johnson R, Spiegelman B, Hanahan D and Wisdom R: Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell Biol 16: 4504-11, 1996.
23. Chen SL, Huang CH, Tsai TC, Lu KY and Tsao YP: The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein. Arch Virol 141: 791-800, 1996.
24. May MJ and Ghosh S: Rel/NF-kappa B and I kappa B proteins: an overview. Semin. Cancer Biol 8: 63-73, 1997.
25. Liou HC and Baltimore D: Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr Opin Cell Biol 5: 477-87, 1993.
26. Arsura M, Fitz Gerald MJ, Fausto N and Sonenshein GE: Nuclear factor kappa B/Rel blocks transforming growth factor betal-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ 8: 1049-59, 1997.
27. Shier MK, Neely EB, Ward MG, Meyers C and Howett MK: Transforming growth factor β1 (TGFβ1) down-regulates expression and function of proliferation-inducing molecules in HPV-transformed cells. In preparation, 1999.